JP4846130B2 - Ｔｃｆ−１ヌクレオチド配列変異体 - Google Patents

Ｔｃｆ−１ヌクレオチド配列変異体 Download PDF

Info

Publication number
JP4846130B2
JP4846130B2 JP2001220567A JP2001220567A JP4846130B2 JP 4846130 B2 JP4846130 B2 JP 4846130B2 JP 2001220567 A JP2001220567 A JP 2001220567A JP 2001220567 A JP2001220567 A JP 2001220567A JP 4846130 B2 JP4846130 B2 JP 4846130B2
Authority
JP
Japan
Prior art keywords
allele
tcf
probe
alleles
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2001220567A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002330755A5 (https=
JP2002330755A (ja
Inventor
ベセア ベゴヴィッチ アン
アンソニー エルリッチ ヘンリー
グループ アンドリュー
アネット ノーブル ジャネル
アレン ペルツ ゲーリー
リン レイノルズ レベッカ
ミラ ウォーカー カレン
ザンゲンベルグ ガブリエラ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of JP2002330755A publication Critical patent/JP2002330755A/ja
Publication of JP2002330755A5 publication Critical patent/JP2002330755A5/ja
Application granted granted Critical
Publication of JP4846130B2 publication Critical patent/JP4846130B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP2001220567A 2000-07-21 2001-07-19 Ｔｃｆ−１ヌクレオチド配列変異体 Expired - Fee Related JP4846130B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21981200P 2000-07-21 2000-07-21
US60/219,812 2000-07-21

Publications (3)

Publication Number Publication Date
JP2002330755A JP2002330755A (ja) 2002-11-19
JP2002330755A5 JP2002330755A5 (https=) 2008-07-10
JP4846130B2 true JP4846130B2 (ja) 2011-12-28

Family

ID=22820882

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001220567A Expired - Fee Related JP4846130B2 (ja) 2000-07-21 2001-07-19 Ｔｃｆ−１ヌクレオチド配列変異体

Country Status (6)

Country Link
US (2) US6656691B2 (https=)
EP (1) EP1174522B1 (https=)
JP (1) JP4846130B2 (https=)
AT (1) ATE360094T1 (https=)
DE (1) DE60127901T2 (https=)
ES (1) ES2286060T3 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100559182C (zh) 2003-08-29 2009-11-11 株式会社东芝 显色试剂、浓度测定试剂盒、浓度测定方法和在该方法中使用的传感器芯片
CN101031649A (zh) * 2004-10-01 2007-09-05 淡马锡生命科学研究院有限公司 水稻凝集素样受体激酶1(OsLRK1)，一个参与植物发育的基因
US20080268442A1 (en) * 2007-04-24 2008-10-30 Igd Intel, Llc Method and system for preparing a blood sample for a disease association gene transcript test
US8135545B2 (en) 2007-11-09 2012-03-13 Iverson Genetic Diagnostics, Inc. System and method for collecting data regarding broad-based neurotoxin-related gene mutation association
US20090125244A1 (en) * 2007-11-09 2009-05-14 Igd Intel Llc Broad-based neurotoxin-related gene mutation association from a gene transcript test

Also Published As

Publication number Publication date
EP1174522B1 (en) 2007-04-18
EP1174522A9 (en) 2002-07-03
EP1174522A2 (en) 2002-01-23
JP2002330755A (ja) 2002-11-19
US20030203395A1 (en) 2003-10-30
DE60127901T2 (de) 2008-01-17
ATE360094T1 (de) 2007-05-15
EP1174522A3 (en) 2004-02-18
DE60127901D1 (de) 2007-05-31
ES2286060T3 (es) 2007-12-01
US6656691B2 (en) 2003-12-02
US20030054350A1 (en) 2003-03-20

Similar Documents

Publication Publication Date Title
TWI236502B (en) Prediction of inflammatory disease
Holm et al. Distinct HLA-C/KIR genotype profile associates with guttate psoriasis
US20120183497A1 (en) Method of Determining Response to Treatment with Immunomodulatory Composition
KR20150058985A (ko) 대사증후군 예측용 ｓｎｐ 마커 및 이의 용도
JP2015510756A (ja) 自閉症のリスクを評価するため遺伝子型決定テスト
JP4140329B2 (ja) 高血圧のリスク診断方法
JP4846130B2 (ja) Ｔｃｆ−１ヌクレオチド配列変異体
Miyamasu et al. Variations in the human CC chemokine eotaxin gene
EP1412531B1 (en) Il-4 receptor sequence variation associated with type 1 diabetes
US7205106B1 (en) Association of polymorphisms in IL4-related genes with autoimmune disease
US20060216712A1 (en) Polynucleotide associated with a type II diabetes mellitus comprising single nucleotide polymorphism, microarray and diagnostic kit comprising the same and method for analyzing polynucleotide using the same
WO2012018258A1 (en) Markers of febrile seizures and temporal lobe epilepsy
WO2006107031A1 (ja) 遺伝子一塩基多型解析によるアトピー性皮膚炎の相対罹患危険率の検出方法
US5688647A (en) Detection of dinucleotide repeat polymorphism in exon 18 of LDL receptor gene for determining predisposition to obesity
EP1405921B1 (en) Detection of susceptibility to autoimmune diseases, especially type 1 diabetes
WO2009103992A1 (en) Genetic variation associated with coeliac disease
WO2011138370A1 (en) Antiviral treatment susceptibility gene and uses thereof
Rouhou et al. Chemokine and chemokine receptor gene polymorphism in Tunisian hemodialysis patients with HCV infection
WO2008026233A2 (en) Single nucleotide polymorphisms on the irak-m gene, related methods, uses and kit for the diagnosis of allergic asthma.
JP2007274986A (ja) ２型糖尿病に対する感受性の判定方法
WO2011147763A1 (en) Biomarkers
WO1999050451A1 (en) Polymorphism i: linkage of asthma to a locus on chromosome 2
JP2004215647A (ja) ２型糖尿病関連遺伝子
JP2018121593A (ja) ウシ白血病ウイルス（ｂｌｖ）プロウイルスロードの判定方法およびその利用
WO2003066905A1 (en) Colorimetric genetic test for clinically significant tnf polymorphism and methods of use thereof

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080522

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080522

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20101026

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20101209

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20101214

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110422

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110621

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110905

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20111004

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20111012

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20141021

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees